bDMARDs Prevent ESRD in Most Patients With AA Amyloidosis
bDMARD therapy preserved renal function in 75% of patients with AA amyloidosis, but the remaining 25% progressed to ESRD despite receiving bDMARD therapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/bdmards-preserve-renal-function-most-patients-aa-amyloidosis-2024a10008yz?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/bdmards-preserve-renal-function-most-patients-aa-amyloidosis-2024a10008yz?src=rss
Comments
Post a Comment